Echo Street Capital Management’s ResMed RMD Stock Holding History

Echo Street Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,015	Closed	-$594K	–	344
2023 Q3	$594K	Sell	4,015 -1,174	-23%	-$212K	0.01%	226
2023 Q2	$1.13M	Buy	5,189 +4,162	+405%	+$928K	0.01%	132
2023 Q1	$225K	Sell	1,027 -6,431	-86%	-$1.4M	﹤0.01%	442
2022 Q4	$1.55M	Buy	+7,458	New	+$1.64M	0.02%	111
2022 Q3	–	Sell	-1,508	Closed	-$316K	–	679
2022 Q2	$316K	Sell	1,508 -2,106	-58%	-$448K	﹤0.01%	417
2022 Q1	$876K	Sell	3,614 -34	-0.9%	-$8.22K	0.01%	265
2021 Q4	$950K	Buy	3,648 +2,686	+279%	+$697K	0.01%	263
2021 Q3	$254K	Buy	+962	New	+$263K	﹤0.01%	542

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Echo Street Capital Management's RMD Position: Q4 2023 in Review

Echo Street Capital Management sold out of ResMed (RMD) in Q4 2023, closing a stake of 4,015 shares — an estimated $594K sold.

Echo Street Capital Management first reported a position in RMD in Q3 2021 and held it in 8 quarters. The position peaked at $1.55M in Q4 2022. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Echo Street Capital Management reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 4,015 ResMed shares in Q4 2023, an estimated $594K.
Echo Street Capital Management first reported a position in ResMed in Q3 2021 and held it in 8 quarters.
Echo Street Capital Management's ResMed position peaked at $1.55M in Q4 2022.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.